By Beverleigh H Piepers
Photo: 3.bp.blogspot.com
Heart and blood vessel disease are some of the most dreaded complications people diagnosed with Type 2 diabetes have to face. It has been found people with diabetes suffer twice as many heart attacks and strokes as anyone without diabetes. Type 2 diabetics usually have high cholesterol levels, which lead to clogged arteries and lack of circulation to the heart muscle and the brain.
In January 2012, the journal Cardiovascular Diabetology reported on the results of a study of the diabetes drug, linagliptin (Tradjenta and Trajenta), and its possible protective effect on the heart and blood vessels.
A total of 5239 volunteers diagnosed with Type 2 diabetes were included in the study. A group that included:
From these results, the researchers concluded linagliptin (Tradjenta and Trajenta) could have benefits for keeping the heart and blood vessels healthy in Type 2 diabetics.
Linagliptin was approved by the US Federal Drug Administration (FDA) in the Spring of 2011 and is marketed by the proprietary name Trajenta. It belongs to the class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. The class also includes sitagliptin, vildagliptin, saxagliptin, dutogliptin, gemigliptin, and alogliptin.
Linagliptin is taken once a day with or without food. It can be taken alone or along with drugs such as metformin, sulphoylureas or pioglitazone. Side effects include inflammation of the nose and throat and inflammation of the pancreas, or low blood sugar when used with sulfonylureas.
Many medications are available for lowering blood sugar levels. If linagliptin can also prevent heart attacks then it can serve an important dual purpose.
Photo: 3.bp.blogspot.com
Heart and blood vessel disease are some of the most dreaded complications people diagnosed with Type 2 diabetes have to face. It has been found people with diabetes suffer twice as many heart attacks and strokes as anyone without diabetes. Type 2 diabetics usually have high cholesterol levels, which lead to clogged arteries and lack of circulation to the heart muscle and the brain.
In January 2012, the journal Cardiovascular Diabetology reported on the results of a study of the diabetes drug, linagliptin (Tradjenta and Trajenta), and its possible protective effect on the heart and blood vessels.
A total of 5239 volunteers diagnosed with Type 2 diabetes were included in the study. A group that included:
- 3319 diabetics received liniagliptin, and the remaining
- 1920 diabetics received the drugs glimepiride (Amaryl) or voglibose (Volix).
From these results, the researchers concluded linagliptin (Tradjenta and Trajenta) could have benefits for keeping the heart and blood vessels healthy in Type 2 diabetics.
Linagliptin was approved by the US Federal Drug Administration (FDA) in the Spring of 2011 and is marketed by the proprietary name Trajenta. It belongs to the class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. The class also includes sitagliptin, vildagliptin, saxagliptin, dutogliptin, gemigliptin, and alogliptin.
- Sitagliptin was approved by the FDA in 2006 and is also known as Januvia.
- Vildagliptin was FDA-approved in 2008, and has the proprietary name Galvus.
- Saxaglipin received its FDA approval in 2009 and is marketed as Onyglyza.
- Dutogliptin and Gemigliptin are still under study.
Linagliptin is taken once a day with or without food. It can be taken alone or along with drugs such as metformin, sulphoylureas or pioglitazone. Side effects include inflammation of the nose and throat and inflammation of the pancreas, or low blood sugar when used with sulfonylureas.
Many medications are available for lowering blood sugar levels. If linagliptin can also prevent heart attacks then it can serve an important dual purpose.
To discover answers to questions you may be asking yourself about Type 2 Diabetes, click on this link... Natural Diabetes Treatments
Clicking on this link will help you to learn more about Type 2 Diabetes Solutions... Beverleigh Piepers RN... the Diabetes Detective.
Beverleigh Piepers is the author of this article. This article can be used for reprint on your website provided all the links in the article are complete and active. Copyright (c) 2011 - All Rights Reserved Worldwide
Article Source: http://EzineArticles.com/?expert=Beverleigh_H_Piepers Clicking on this link will help you to learn more about Type 2 Diabetes Solutions... Beverleigh Piepers RN... the Diabetes Detective.
Beverleigh Piepers is the author of this article. This article can be used for reprint on your website provided all the links in the article are complete and active. Copyright (c) 2011 - All Rights Reserved Worldwide
Irrespective of receiving daily oral or future in jectable depot therapies, these require health care visits for medication and monitoring of safety and response. If patients are treated early enough, before a lot of immune system damage has occurred, life expectancy is close to normal, as long as they remain on successful treatment. However, when patients stop therapy, virus rebounds to high levels in most patients, sometimes associated with severe illness because I have gone through this and even an increased risk of death. The aim of “cure”is ongoing but I still do believe my government made millions of ARV drugs instead of finding a cure. for ongoing therapy and monitoring. ARV alone cannot cure HIV as among the cells that are infected are very long-living CD4 memory cells and possibly other cells that act as long-term reservoirs. HIV can hide in these cells without being detected by the body’s immune system. Therefore even when ART completely blocks subsequent rounds of infection of cells, reservoirs that have been infected before therapy initiation persist and from these reservoirs HIV rebounds if therapy is stopped. “Cure” could either mean an eradication cure, which means to completely rid the body of reservoir virus or a functional HIV cure, where HIV may remain in reservoir cells but rebound to high levels is prevented after therapy interruption.Dr JAMES Herbal Medicine makes me believes there is a hope for people suffering from ACUTE MYELOFIBROSIS, ALZHEIMER's symptoms, BREAST CANCER, DIABETES, HAIR LOSS AND HAIR TREATMENT, KIDNEY DISEASES, LEUKEMIA, MYELOID LEUKEMIA, STEM CELL TREATMENT,Parkinson's disease,Schizophrenia,Cancer,Scoliosis,Fibromyalgia,Fluoroquinolone Toxicity
ReplyDeleteSyndrome Fibrodysplasia Ossificans Progressiva.Fatal Familial Insomnia Factor V Leiden Mutation ,Epilepsy Dupuytren's disease,Desmoplastic small-round-cell tumor Diabetes ,CARDIAC disease,Creutzfeldt–Jakob disease,Cerebral Amyloid Angiopathy, Ataxia,Arthritis,Amyotrophic Lateral Sclerosis,Alzheimer's disease,Adrenocortical carcinoma.Asthma,Allergic disease HIV & Aids,Herpes ,Copd,Diabetes,Hepatitis,I red about him online how he cured Tasha and Tara so I contacted him on >drjamesherbalmix@gmail.com< even talked on >whatsapps +2348152855846< believe me it was easy I drank his herbal medicine for two weeks and I was cured just like that isn't Dr James a wonder man? Yes he is! I thank him so much so I will advise if you are suffering from one of those diseases. Please do contact him and get permanent treatment with his powerful herbal mix now he's a good man.